In previous studies, CCR1 blockade with the antagonist CCX721 reduced tumour burden and osteolysis in a mouse model of myeloma bone disease [71], while another CCR1 antagonist, BL5923, was able to suppress liver metastasis from colorectal cancer [72]. Here, CCR1 is linked to colorectal cancer.